您的位置: 首页 > 农业专利 > 详情页

Anti- IL1RAP antibody, in conjunction with the bispecific antigen binding molecules and application thereof of IL1RAP and CD3
专利权人:
JANSSEN PHARMACEUTICA N.V.
发明人:
BRADLEY HEIDRICH,BRANDY STRAKE,DARLENE PIZUTTI,FRANCOIS GAUDET,JAMIE FISHER,JENNIFER NEMETH-SEAY,MARK SALVATI,RICARDO ATTAR,ROSA CARDOSO,THAI DINH,WALTER NISHIOKA
申请号:
BR112018008908
公开号:
BR112018008908A2
申请日:
2016.11.01
申请国别(地区):
BR
年份:
2018
代理人:
摘要:
There is provided herein the antibody of specific binding IL1RAP.Invention further describes can encode the related polynucleotides of provided IL1RAP specific antibodies or antigen-binding fragment, express the cell of provided antibody or antigen-binding fragment and the antibody or antigen-binding fragment of relevant carriers and detectable label.In addition, also describing the method for using provided antibody.For example, the antibody provided can be used for diagnosing, treat or monitor the progress, recession or stability of IL1RAP expression type cancers;For determining whether cancer patient should receive treatment;Or for determining whether subject suffers from IL1RAP expression type cancers, and therefore may be adapted to be treated for the multi-specificity antibody of IL1RAP and CD3 as described herein with IL1RAP specific anti-cancer therapeutic agents are all.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/
相关发明人
相关专利

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充